ProShares UltraShort Nasdaq BiotechnologyProShares UltraShort Nasdaq BiotechnologyProShares UltraShort Nasdaq Biotechnology

ProShares UltraShort Nasdaq Biotechnology

No trades
Buy BIS

Key stats


Assets under management (AUM)
‪3.39 M‬USD
Fund flows (1Y)
‪−449.70 K‬USD
Dividend yield (indicated)
4.18%
Discount/Premium to NAV
3.1%

About ProShares UltraShort Nasdaq Biotechnology


Issuer
ProShare Advisors LLC
Brand
ProShares
Expense ratio
0.95%
Home page
Inception date
Apr 7, 2010
Index tracked
NASDAQ / Biotechnology
Management style
Passive
BIS is one available fund that provides exposure to the biotech space aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Exchange-specific
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
What's in the fund
Exposure type
Bonds, Cash & Other
Cash
Government
Bonds, Cash & Other100.00%
Cash56.25%
Government43.75%

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.